NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

Mutual Fund Deals : SBI MUTUAL FUND on 21 Feb

[fetch_key]
Discover the nuances of recent mutual fund deals involving prominent clients through our detailed analysis. These large-scale transactions are more than just financial moves; they provide a window into the investment patterns and strategic priorities that shape today’s dynamic market environment. Monitoring these deals helps investors comprehend the institutional investment behaviors that foretell shifts in market trends. By staying updated on these developments, investors can align their strategies with the prevailing economic conditions and enhance their market foresight.
This section outlines the recent activities within the mutual fund concerning clients: . Continue reading to delve deeper into these significant developments.

Recent Block Deals:

Company Client Name Buy/Sell Qty Traded Price Trader Name
Alkem Laboratories Sbi Mutual Fund Buy 641K 4680.00 Samprada&nanhamati Singh Family Trust

Alkem Laboratories :

641K shares were purchased by Sbi Mutual Fund of MutualFund, with the transaction occurring at a price of ₹4680.00 per share. Subsequently, the shares were sold by Samprada&nanhamati Singh Family Trust at the same price per share. Recent activity in the mutual fund data shows Sbi Mutual Fund’s transaction with Alkem Laboratories shares, marking a key adjustment in their investment approach, which could influence broader market perceptions.

Join our telegram for more updates

Stay Updated with Our YouTube Videos

Related Post